Treatment and Care

The animation educates viewers on topics related to drug-resistant TB and multidrug-resistant TB, such as treatment plans, basic information on multidrug-resistant TB, and the importance of medication adherence.

The animation educates viewers on topics related to drug-resistant TB and multidrug-resistant TB, such as treatment plans, basic information on multidrug-resistant TB, and the importance of medication adherence.

The animation educates viewers on topics related to drug-resistant TB and multidrug-resistant TB, such as treatment plans, basic information on multidrug-resistant TB, and the importance of medication adherence.

The video describes ways to effectively manage active TB by providing information on TB testing, diagnosis, and treatment.

The video describes ways to effectively manage active TB by providing information on TB testing, diagnosis, and treatment.

The video describes ways to effectively manage active TB by providing information on TB testing, diagnosis, and treatment.

This video illustrates the interactions between TB and HIV, including their impact on the immune system, TB testing, and TB treatment.

This information sheet discusses the link between STDs and HIV. It explains how individuals with STDS have an increased susceptibility to HIV and individuals with HIV have increased infectiousness. The information sheet discusses how STD treatment can slow the spread of HIV and the implications for HIV and STD prevention programs. Information is provided for accessing the services of national health organizations.

This internet file educates patients about hepatitis C treatment. It discusses the drugs approved for treatment of hepatitis C, why medications are used to treat the disease and how they are used, how likely it that the treatment will work, how the doctor monitors patients during treatment, side effects and how to cope with them, how patients can improve the chances of responding to treatment, why some patients take treatment and others do not, and where to get more information on the subject.

This information sheet discusses treatment for individuals with latent tuberculosis infection (LTBI), with the purpose of this treatment being the reduction of the risk that the infection will progress to TB disease. It explains how the health care provider determines whether the individual with a positive tuberculin skin test (TST) or blood test result is a candidate for treatment of LTBI and how the most effective regimen is chosen; presents LTBI treatment regimens; and describes monitoring during treatment, drug-drug interactions, particularly for HIV-infected patients, and side effects.